Ariosa Diagnostics

About:

Ariosa Diagnostics is a molecular diagnostics company focused on improving patient care.

Top Investors: Meritech Capital Partners, Domain Associates, Venrock

Description:

Ariosa Diagnostics is a non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, which is one of the most widely studied tests utilized in prenatal screening.

Total Funding Amount:

$67.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Jose, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)ariadx.com

Founders:

Ken Song

Number of Employees:

51-100

Last Funding Date:

2012-01-09

IPO Status:

Private

Industries: